After multiple testing correction and co-localization analysis (Supplementary Table S9), genetically predicted expression levels of KCNJ5 was associated with increases in AF risk in atrial appendage (OR 1.293, 95% CI 1.169–1.431; PPH4 = 0.97). Here, KCNJ5 is linked to atrial fibrillation.